Free Trial
OTCMKTS:BIOVF

Swedish Orphan Biovitrum (BIOVF) Stock Price, News & Analysis

Swedish Orphan Biovitrum logo
$29.25 0.00 (0.00%)
As of 06/30/2025

About Swedish Orphan Biovitrum Stock (OTCMKTS:BIOVF)

Key Stats

Today's Range
$29.25
$29.25
50-Day Range
$27.06
$31.99
52-Week Range
$24.08
$32.25
Volume
96 shs
Average Volume
66 shs
Market Capitalization
$10.41 billion
P/E Ratio
27.59
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive BIOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter.

BIOVF Stock News Headlines

Sobi and Apellis Amend Royalty Agreement for Aspaveli
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

BIOVF Stock Analysis - Frequently Asked Questions

Swedish Orphan Biovitrum's stock was trading at $27.66 at the start of the year. Since then, BIOVF stock has increased by 5.7% and is now trading at $29.25.
View the best growth stocks for 2025 here
.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) released its earnings results on Tuesday, April, 29th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.04. The business earned $641.33 million during the quarter, compared to analyst estimates of $644.12 million. Swedish Orphan Biovitrum had a trailing twelve-month return on equity of 10.54% and a net margin of 15.07%.

Shares of BIOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/29/2025
Today
7/02/2025
Next Earnings (Estimated)
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOVF
CIK
N/A
Fax
N/A
Employees
1,772
Year Founded
2001

Profitability

Trailing P/E Ratio
27.59
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$367.52 million
Pretax Margin
16.93%

Debt

Sales & Book Value

Annual Sales
$2.46 billion
Cash Flow
$2.05 per share
Price / Cash Flow
14.26
Book Value
$10.71 per share
Price / Book
2.73

Miscellaneous

Free Float
N/A
Market Cap
$10.41 billion
Optionable
Not Optionable
Beta
0.43

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:BIOVF) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners